World Morning Star
NHS picking up the tab for test profiteers
CAMPAIGNERS say the NHS is being left to “pick up the bill” after a study showed private health firms peddling tests that “lack evidence of benefit.” Researchers at the University of St Andrews looked
English (original) ·Read in Deutsch ⇄
Britain / 17 November 2026 Unions back challenge to Mahmood migrant attack 17 November 2026 Big Tech / 17 November 2026 Scotland’s children’s commissioner ‘concerned’ about data centre guidance 17 November 2026 Transport / 17 November 2026 TfL staff say they face ‘shocking’ levels of abuse 17 November 2026 Industrial / 17 November 2026 Unions demand real pay rise for 1.4 million council workers 17 November 2026 Industrial / 17 November 2026 Merseyside dockworkers secure pay victory 17 November 2026 Britain / 17 November 2026 Government accused of inaction over ‘race realist’ talk at Oxford University 17 November 2026 CAMPAIGNERS say the NHS is being left to “pick up the bill” after a study showed private health firms peddling tests that “lack evidence of benefit.”
Researchers at the University of St Andrews looked at the “vast array” of health tests on offer from 50 private-sector firms, from full blood tests to full body MRI scans and ranging in cost from £6.99 to £14,000, which are marketed at people not displaying any symptoms.
The study, published today in BMJ Open, found all the tests were either not recommended or available on the NHS and that 16 of the firms made inaccurate claims that they could extend life “despite a lack of evidence.”
It found 70 per cent failed to explain tests’ limitations or potential harms and many directed customers to their own NHS doctor on receiving their results.
Researchers warned: “Given the growth in this sector, urgent, co-ordinated actions across regulators are required to protect consumers from poor value or harmful tests and limit negative impact to the NHS.”
Keep Our NHS Public co-chairman Dr John Puntis said companies “offering ‘screening’ tests to the worried well are motivated by profit, rather than concern for patients.”
Turning to the impact on the NHS, he added: “The private companies deal with mildly abnormal results by directing clients to the NHS.
“Often these results are of no significance but create patient anxiety and additional expense in terms of need for reassurance and sometimes repeat or further investigations.
“The companies should be made to take responsibility both for counselling patients before tests are performed and for responding appropriately to any abnormal results.
“The NHS should not be made to pick up the bill for problems created unnecessarily through the poor medical practice of commercial organisations.”